ML-SA1, a selective TRPML agonist, inhibits DENV2 and ZIKV by promoting lysosomal acidification and protease activity

Publication date: Available online 26 August 2020Source: Antiviral ResearchAuthor(s): Zhiqiang Xia, Luyao Wang, Songryong Li, Wei Tang, Fang Sun, Yingliang Wu, Lixia Miao, Zhijian Cao
Source: Antiviral Therapy - Category: Virology Source Type: research